SCHEMBL20139853

SCHEMBL20139853

COC(=O)c1[nH]ncc1I

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.49
KDM4C Q9H3R0 1/20 0.42
MAPK8 P45983 1/20 0.40
MAPK9 P45984 1/20 0.40
MAPK10 P53779 1/20 0.40
MAPK1 P28482 2/20 0.38
PDPK1 O15530 1/20 0.37
NPSR1 Q6W5P4 2/20 0.35
ALDH1A1 P00352 8/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
POLB P06746 2/20 0.35
ATM Q13315 1/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
KDM4E B2RXH2 2/20 0.34
STAT3 P40763 1/20 0.34
HIF1A Q16665 1/20 0.34
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
CYP1A2 P05177 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL370052 0.82
SCHEMBL370614 0.80 ALDH1A1 (0.53) TSHRALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL1430587 0.78 TSHR (0.50) TSHRKDM4CMAPK8MAPK9MAPK10
SCHEMBL12233266 0.78 TSHR (0.65) TSHRKDM4CMAPK8MAPK9MAPK10
SCHEMBL25424983 0.77 TSHR (0.49) TSHRKDM4CMAPK8MAPK9MAPK10
SCHEMBL30107016 0.77 TSHR (0.49) TSHRKDM4CMAPK8MAPK9MAPK10
SCHEMBL21643603 0.77 PDPK1 (0.60) TSHRKDM4CMAPK8MAPK9MAPK10
SCHEMBL16427401 0.77 TSHR (0.49) TSHRKDM4CMAPK8MAPK9MAPK10
SCHEMBL15519155 0.77 TSHR (0.49) TSHRKDM4CMAPK8MAPK9MAPK10
SCHEMBL25293024 0.77 TSHR (0.45) TSHRKDM4CMAPK8MAPK9MAPK10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112424195-B Fused lactam derivatives 住友制药株式会社 2025-03-25 CN disclosed
US-20250084090-A1 SUBSTITUTED LACTAMS SHOWING SEROTONIN 5-HT RECEPTOR ACTIVITY Sumitomo Pharma Co., Ltd. (JP) 2025-03-13 US disclosed
US-12180213-B2 Substituted pyrazoles showing serotonin 5-HT receptor activity SUMITOMO PHARMA CO. LTD. (JP) 2024-12-31 US disclosed
US-20230008875-A1 SUBSTITUTED LACTAMS SHOWING SEROTONIN 5-HT RECEPTOR ACTIVITY Sumitomo Pharma Co., Ltd. (JP) 2023-01-12 US disclosed
US-11466007-B2 Substituted lactams showing serotonin 5-HT receptor activity Sumitomo Pharma Co., Ltd. (JP) 2022-10-11 US disclosed
EP-3828182-A1 FUSED RING LACTAM DERIVATIVES Sumitomo Dainippon Pharma Co., Ltd. (JP) 2021-06-02 EP disclosed
CN-112424195-A Condensed lactam derivatives 大日本住友制药株式会社 2021-02-26 CN disclosed
US-10745401-B2 Condensed lactam derivative SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2020-08-18 US disclosed
US-20200255432-A1 CONDENSED LACTAM DERIVATIVE SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2020-08-13 US disclosed
US-20200172543-A1 CONDENSED LACTAM DERIVATIVE SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2020-06-04 US disclosed
WO-2018089493-A1 PYRROLE mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. (US) 2018-05-17 WO disclosed
WO-2018089493-A1 PYRROLE mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. (US) 2018-05-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200255432-A1 CONDENSED LACTAM DERIVATIVE PSEN1, GRIN1, HDAC1 TSHR 4630/4885KDM4C 2934/4885MAPK8 3990/4885
US-20250084090-A1 SUBSTITUTED LACTAMS SHOWING SEROTONIN 5-HT RECEPTOR ACTIVITY HTR1A, HTR5A, TPH1 TSHR 340/4885KDM4C 4227/4885MAPK8 2737/4885
US-12180213-B2 Substituted pyrazoles showing serotonin 5-HT receptor activity HTR5A, HTR1A, TPH1 TSHR 257/4885KDM4C 3998/4885MAPK8 1355/4885
US-10745401-B2 Condensed lactam derivative PSEN1, GRIN1, HDAC1 TSHR 4630/4885KDM4C 2934/4885MAPK8 3990/4885
US-11466007-B2 Substituted lactams showing serotonin 5-HT receptor activity HTR1A, HTR5A, TPH1 TSHR 340/4885KDM4C 4227/4885MAPK8 2737/4885
US-20230008875-A1 SUBSTITUTED LACTAMS SHOWING SEROTONIN 5-HT RECEPTOR ACTIVITY HTR1A, HTR5A, TPH1 TSHR 340/4885KDM4C 4227/4885MAPK8 2737/4885
US-20200172543-A1 CONDENSED LACTAM DERIVATIVE PSEN1, GRIN1, HDAC1 TSHR 4630/4885KDM4C 2934/4885MAPK8 3990/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.